The FDA has published a discussion paper proposing new regulatory frameworks for generative AI-enabled medical devices, recognizing that continuous learning systems and open-ended inputs present unique safety challenges. The agency is seeking feedback from manufacturers, clinicians, researchers, and the public

Diagnostics

Categories